CIRCA Scientific announces FDA clearance for new esophageal temperature probe that is visible on 3D cardiac mapping systems.
CIRCA SCIENTIFIC HAS RECEIVED FDA CLEARANCE FOR NEW ESOPHAGEAL TEMPERATURE PROBE THAT IS VISIBLE ON 3D CARDIAC MAPPING SYSTEMS
S-CATH™ M is the only rapid-response, high-density esophageal temperature probe that is visible on 3D cardiac mapping systems
Englewood, CO, March 3, 2021 – CIRCA Scientific, Inc. announced today that its S-CATH™ M Esophageal Temperature Probe is now cleared for sale in the United States. The new S-CATH M Probe can be visualized on 3D Cardiac Mapping Systems, which may help physicians reduce their dependence on fluoroscopy. It is the only commercially available multi-sensor esophageal temperature probe that provides high-density, edge-to-edge coverage of the esophagus and is visible on 3D cardiac mapping systems.
Esophageal temperature probes can be used to alert physicians to critical esophageal temperature changes that may occur during cardiac ablation procedures performed in the operating room (OR) or electrophysiology (EP) lab. However, many physicians currently depend on fluoroscopy to place, position, and reposition their esophageal temperature probe during a procedure. The use of fluoroscopy requires physicians and lab personnel to wear protective lead aprons to shield themselves from radiation exposure.
The new S-CATH M has four electrodes that are placed down the centerline of the probe, enabling it to be placed, positioned, and visualized on 3D mapping without depending solely on fluoroscopy.1 In addition, S-CATH M features a proprietary micro-electrode design that limits the amount of exposed metal to only what is absolutely necessary to be detected on 3D cardiac mapping systems, minimizing the opportunity for radiofrequency (RF) interaction. Research has shown that esophageal temperature probes with fully exposed metal electrodes may be inadvertently heated when used in close proximity to the RF field.2-4
“We designed S-CATH M to support physicians’ efforts to minimize the amount of radiation their patients and staff are exposed to during their procedures without compromising on the features that set our portfolio of products apart” said Lee Geist, President, and CEO of CIRCA Scientific. “CIRCA Scientific is proud to join a growing community of medical device manufacturers meeting the demand for technology that enables reduced fluoroscopy use in the OR and EP Lab.”
About CIRCA Scientific
For the last 10 years, CIRCA Scientific has been the global leader in Advanced Esophageal Temperature Monitoring Solutions. CIRCA’s Esophageal Temperature Monitoring Systems provide physicians with rapid, reliable data to help them avoid excessive heating/cooling of the esophagus during therapeutic procedures performed in the OR or EP Lab. For more information, visit www.circascientific.com and connect with us on Twitter and LinkedIn.
Media Contact: info@circascientific.com
CS-PR001-0322 © CIRCA Scientific, Inc., 2022. All rights reserved. S-CATH, CIRCA Scientific, and the CIRCA Scientific logo are trademarks of CIRCA Scientific, Inc. U.S. Patents 9,155,476 B2 and 9,668,655. Other U.S. and foreign patents pending. CAUTION: US law restricts this device to sale by or on the order of a physician. Before use, consult instructions for use supplied with this device for indications, contraindications, side effects, warnings, and precautions.
1 Always make sure to have a primary and secondary imaging source available and retain the ability to verify probe location with fluoroscopy if needed.
2 Péréz, J. J., et al. “Electrical and Thermal Effects of Esophageal Temperature Probes on Radiofrequency Catheter Ablation of Atrial Fibrillation: Results from a Computational Modeling Study.” Journal of Cardiovascular Electrophysiology (2015): 556-564.
3 Müller, P., et al. “Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes.” Heart Rhythm (2015): 1464-1469.
4 Halbfass, P., et al. “Incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation using an oesophageal temperature probe with insulated thermocouples: a comparative controlled study.” Europace (2017): 385-391.